Average Co-Inventor Count = 2.76
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alcon, Inc. (4 from 1,177 patents)
4 patents:
1. 7838507 - RNAi inhibition of CTGF for treatment of ocular disorders
2. 7622454 - RNAi inhibition of CTGF for treatment of ocular disorders
3. 7592324 - RNAi-mediated inhibition of ocular targets
4. 7351407 - Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies